Using platelet-like particles to stop bleeding and improve healing
Anti-microbial platelet-like-particles to treat internal bleeding and augment subsequent healing
This study is looking at a new treatment using tiny particles that act like platelets to help stop bleeding and heal wounds better for people who have been injured, especially those at risk of bleeding too much or getting infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina State University Raleigh NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project ID | NIH-11090495 on NIH RePORTER |
What this research studies
This research investigates the use of specially designed platelet-like particles to address uncontrolled bleeding after trauma, which is a major cause of death. The approach focuses on enhancing the body's natural clotting process and improving wound healing by targeting specific proteins in the wound environment. By utilizing microgels that mimic platelets, the study aims to create a more effective treatment for patients suffering from traumatic injuries, particularly those with concurrent bleeding and infection risks. The methodology includes developing these particles to bind to fibrin, a key component in blood clotting, to stabilize clots and promote healing.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults who have experienced traumatic injuries leading to uncontrolled bleeding.
Not a fit: Patients with chronic bleeding disorders or those not experiencing trauma-related bleeding may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce mortality and complications associated with traumatic bleeding and improve recovery outcomes for patients.
How similar studies have performed: Previous research has shown promise in using similar approaches to enhance clotting and healing, indicating potential for success in this novel application.
Where this research is happening
Raleigh, United States
- North Carolina State University Raleigh — Raleigh, United States (Active)
Researchers
- Principal investigator: Brown, Ashley Carson — North Carolina State University Raleigh
- Study coordinator: Brown, Ashley Carson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.